Novo Nordisk has reported the first mid-stage clinical data with its triple G agonist for diabetes in China, as it starts an international trials programme. The drug candidate, UBT251, acts on GLP-1, ...
A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law ...
Nasdaq Data Link APIs provide a flexible and efficient method of delivery for real-time exchange data and other financial information. Stock market data is made available through a suite of streaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results